Bio-Techne (NASDAQ: TECH) reported Q3 EPS of $0.56, $0.05 better than the analyst estimate of $0.51. Revenue for the quarter came in at $316.18 million versus the consensus estimate of $317.51 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.